Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects? — TARGET

Prostate Cancer Diagnosis Clinical Trial

Official title:
AOP2780 - Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

Status Recruiting

Clinical Trial Summary

Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer

Clinical Trial Description

To assess whether a larger caliber (16G) prostate biopsy needle increases the diagnostic capability of prostate neoplasia compared to a smaller caliber (18G) needle, while keeping perioperative complications constant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06420115
Study type	Interventional
Source	University Hospital Padova
Contact	Fabio F. Zattoni, MD, PhD
Phone	0498212730
Email	fabio.zattoni@unipd.it
Status	Recruiting
Phase	N/A
Start date	June 1, 2024
Completion date	May 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05820724` - PSMA PET Scan and mpMRI for Prostate Cancer Detection	Phase 2
Recruiting	`NCT05818631` - Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer
Completed	`NCT04822272` - MagneThermoPro : Magnetic Resonance Thermography of Human Prostate	N/A
Recruiting	`NCT06000046` - PROVIZ - a Machine Learning Software, to Support Targeting of Prostate Biopsies on MR Images in Biopsy-naive Patients	N/A